CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•06/11/2026•16:05 ET
0
Key Highlights
- ➤CareDx granted RSUs covering 33,375 shares to 21 new employees
- ➤RSUs vest over four years under CareDx’s 2025 Inducement Equity Incentive Plan
- ➤Grants issued under Nasdaq Listing Rule 5635(c)(4)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants.
Get started
Create a free account to read the full story.